These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16329348)

  • 21. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
    Hampel F; Ratner P; Mansfield L; Meeves S; Liao Y; Georges G
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):354-61. PubMed ID: 14582814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.
    Bernstein DI; Levy AL; Hampel FC; Baidoo CA; Cook CK; Philpot EE; Rickard KA
    Clin Exp Allergy; 2004 Jun; 34(6):952-7. PubMed ID: 15196285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.
    Jen A; Baroody F; de Tineo M; Haney L; Blair C; Naclerio R
    J Allergy Clin Immunol; 2000 Apr; 105(4):732-8. PubMed ID: 10756223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
    Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
    J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis.
    Abdelaziz MM; Devalia JL; Khair OA; Bayram H; Prior AJ; Davies RJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):410-20. PubMed ID: 9525460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis.
    Horak F; Stübner P; Zieglmayer R; Kavina A; De Vos C; Burtin B; Donnelly F
    Int Arch Allergy Immunol; 2001 May; 125(1):73-9. PubMed ID: 11385291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
    Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of natural allergens exposure on serum concentration of soluble form of intercellular adhesion molecule 1 in patients with seasonal airway allergy].
    Kroczyńska-Bednarek J; Pietrzkowicz M; Górski P; Grzelewska-Rzymowska I
    Pol Merkur Lekarski; 2007 Feb; 22(128):140-5. PubMed ID: 17598660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
    Milgrom H; Kittner B; Lanier R; Hampel FC
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):358-63. PubMed ID: 17941284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with allergic rhinoconjunctivitis.
    Turgay M; Keskin G; Kminkli G; Sentürk T; Tutkak H; Duman M; Tokgöz G
    Allergol Immunopathol (Madr); 1996; 24(3):129-31. PubMed ID: 8766745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
    Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
    J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH; Howland WC; Arastu R; Philpot EE; Klein KC; Baidoo CA; Faris MA; Rickard KA
    Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J; Caldwell MF; Wolthers OD
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of allergen immunotherapy on soluble adhesion molecules.
    Pereira-Santos MC; Pregal AL; Spínola-Santos A; Alonso E; Palma-Carlos ML; Palma-Carlos AG
    Allerg Immunol (Paris); 2001 Jun; 33(6):225-8. PubMed ID: 11505805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics, safety and tolerability of an oral suspension of fexofenadine for children with allergic rhinitis.
    Segall N; Grubbe RE; Levy AL; Maloney MJ; Nayak AS; Kittner B; Quesada JT
    Allergy Asthma Proc; 2008; 29(4):380-5. PubMed ID: 18702885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
    Prenner BM; Capano D; Harris AG
    Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.